학술논문
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology.
Document Type
Article
Author
Source
Subject
*HEART failure
*DRUG prescribing
*ACE inhibitors
*ADRENERGIC beta blockers
*KIDNEY diseases
*
*
*
*
Language
ISSN
1388-9842
Abstract
Aims: Recent studies have shown that prescription rates and doses of recommended drugs for chronic heart failure (CHF) are not optimal in daily practice. The aim of the Impact-Reco programme was to analyse prescription rates of CHF drugs in stable outpatients with CHF related to left ventricular (LV) systolic dysfunction in two similar surveys in France. [ABSTRACT FROM PUBLISHER]